Setpoint Medical Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:Setpoint Medical Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011272
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
SetPoint Medical Inc. (SetPoint Medical) is a biotechnology company that develops bioelectronic therapies for the treatment of inflammatory autoimmune diseases. The company employs a scientific platform, which is based on inflammatory reflex. The company’s bioelectronic medicine platform under development triggers the vagus nerve to activate the body’s natural inflammatory reflex, which produces a powerful systemic anti-inflammatory effect. Its platform consists of an implantable pill sized bioelectronic device (micro regulator), a wireless charger and iPad prescription pad application. The company reported encouraging response in trials in rheumatoid arthritis and Crohn’s disease. It intends to evaluate the medicine in other inflammatory diseases. SetPoint Medical is headquartered in Valencia, California, the US.

Setpoint Medical Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Setpoint Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Setpoint Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Setpoint Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Setpoint Medical Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Setpoint Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Setpoint Medical Inc, Medical Equipment, Deal Details 10
Venture Financing 10
SetPoint Medical Raises USD30 Million in Series D Financing 10
SetPoint Medical Raises Funds through Venture Financing 12
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 14
Setpoint Medical Raises US$27 Million In Venture Financing 16
Partnerships 17
Sagentia Enters Into Co-Development Agreement With Setpoint Medical 17
Setpoint Medical Inc – Key Competitors 18
Setpoint Medical Inc – Key Employees 19
Setpoint Medical Inc – Locations And Subsidiaries 20
Head Office 20
Recent Developments 21
Corporate Communications 21
Jul 31, 2017: SetPoint Medical Appoints Terry Bevirt as VP of Clinical Affairs 21
Jun 15, 2017: SetPoint Medical Appoints David Chernoff, MD as Chief Medical Officer 22
Sep 21, 2016: SetPoint Medical’s Progress Fuels Corporate Headquarters Relocation 23
Sep 12, 2016: SetPoint Medical Expands Management Team to Support Advancement of Bioelectronic Medicine Platform 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
Setpoint Medical Inc, Medical Equipment, Key Facts 2
Setpoint Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Setpoint Medical Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Setpoint Medical Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Setpoint Medical Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Setpoint Medical Inc, Deals By Market, 2011 to YTD 2017 8
Setpoint Medical Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
SetPoint Medical Raises USD30 Million in Series D Financing 10
SetPoint Medical Raises Funds through Venture Financing 12
Setpoint Medical Raises Additional USD15 Million in Series C Venture Financing 14
Setpoint Medical Raises US$27 Million In Venture Financing 16
Sagentia Enters Into Co-Development Agreement With Setpoint Medical 17
Setpoint Medical Inc, Key Competitors 18
Setpoint Medical Inc, Key Employees 19

★海外企業調査レポート[Setpoint Medical Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Flisom AG:電力:M&Aディール及び事業提携情報
    Summary Flisom AG (Flisom) is a manufacturer and distributor of solar modules that produces and commercializes flexible solar modules based on CIGS photovoltaic technologies. The company offers products such as ultralight solar modules, thin film photovoltaic solar modules, lightweight solar modules …
  • Pharm-Olam International Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Pharm-Olam International Ltd (Pharm-Olam) is a contract research organization (CRO) which offers clinical research services to the pharmaceutical, biotechnology and medical device industries. The organization's service offerings include medical writing, monitoring, regulatory and ethics subm …
  • People’S Bank:企業の戦略・SWOT・財務分析
    People'S Bank - Strategy, SWOT and Corporate Finance Report Summary People'S Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tompkins Financial Corp (TMP)
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Carmat SAS (ALCAR)-医療機器分野:企業M&A・提携分析
    Summary Carmat SAS (Carmat) is a medical equipment company that offers artificial organs. The company offers development of innovative artificial organs, artificial heart and other vital organs. Its artificial heart products consists of an implantable heart, and components which help connect to an e …
  • Afianzadora Latinoamericana Cia de Seguros S.A.:企業の戦略・SWOT・財務情報
    Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report Summary Afianzadora Latinoamericana Cia de Seguros S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Premier Foods plc (PFD):企業の財務・戦略的SWOT分析
    Premier Foods plc (PFD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • National Petroleum Services Co (NAPESCO):石油・ガス:M&Aディール及び事業提携情報
    Summary National Petroleum Services Co (NAPESCO), a subsidiary of Qurain Petrochemical Industries Co, is an oil and gas service company that offers upstream and downstream services. The company's upstream oil field services includes filtration, well cementing services, downhole tools, casing hardwar …
  • Hokkaido Gas Co Ltd (9534):企業の財務・戦略的SWOT分析
    Summary Hokkaido Gas Co Ltd (Hokkaido Gas), a subsidiary of Kita Gas Group is an oil and gas company that distributes petroleum products. The company’s business activities include gas business, heat supply, power supply, purification and sale of gas by-products, and production and sale of gas applia …
  • The Quaker Oats Company:企業の戦略・SWOT・財務分析
    The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report Summary The Quaker Oats Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ampac Packaging, LLC:企業の戦略・SWOT・財務情報
    Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report Summary Ampac Packaging, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Isagen SA ESP:企業の戦略的SWOT分析
    Isagen SA ESP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • PetroMaroc Corporation Plc (PMA):企業の財務・戦略的SWOT分析
    Summary PetroMaroc Corporation Plc (Petromaroc), formerly Longreach Oil and Gas Ltd, is an oil and gas exploration and development company that evaluates, acquires, explores and develops oil and gas properties in Morocco. The company holds interests in the Sidi Moktar licence area which includes geo …
  • Ashok Leyland Limited:企業のM&A・事業提携・投資動向
    Ashok Leyland Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ashok Leyland Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Callon Petroleum Co (CPE):石油・ガス:M&Aディール及び事業提携情報
    Summary Callon Petroleum Co (CPC) is an oil and gas company that offers building reserves and production of onshore and offshore oil and natural gas. The company carries out acquisition, development, exploration, and exploitation of unconventional onshore, oil, and natural gas reserves. It operates …
  • Oil Refineries Ltd (ORL):企業の財務・戦略的SWOT分析
    Oil Refineries Ltd (ORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CVR Energy, Inc.:企業の戦略・SWOT・財務情報
    CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary CVR Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Terumo Corp (4543):企業の財務・戦略的SWOT分析
    Terumo Corp (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Trevena Inc (TRVN):企業の財務・戦略的SWOT分析
    Summary Trevena Inc (Trevena) is a biotechnology company that discovers and develops G-protein coupled receptor targeted medicines. The company provides products such as RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination w …
  • Visser & Smit Hanab BV:企業の戦略的SWOT分析
    Visser & Smit Hanab BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆